| Product Information |
|
| Registration Number |
DR-XY44202
|
| Generic Name |
Fluticasone Furoate + Vilanterol (As Trifenatate)
|
| Brand Name |
Relvar Ellipta
|
| Dosage Strength |
100mcg/25mcg (eq. to 92mcg/22 mcg delivered dose
|
| Dosage Form |
Dry Powder For Inhalation
|
| Classification |
Prescription Drug (Rx)
|
| Pharmacologic Category |
-
|
| Packaging |
in a box of 1-sealed foil laminate tray
containing 1-ligth grey body, pale blue
mouthpiece cover and dose counter plastic
inhaler x 30 doses and a dessicanr packet
|
| Manufacturer |
Glaxo Operations UK Ltd.
|
| Country of Origin |
United Kingdom
|
| Trader |
|
| Importer |
GlaxoSmithKline Philippines, Inc.
|
| Distributor |
|
| Application Type |
Initial [from Monitored Release]
|
| Issuance Date |
17 March 2022
|
| Expiry Date |
13 February 2025
|